Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7100 results

Singapore reports sharp downturn in biomedical manufacturing for September

24-10-2014

On a year-on-year basis, Singapore’s manufacturing output contracted 1.2% in September 2014, mainly…

PharmaceuticalSingapore

Experts' comments on GSK floating its HIV business

24-10-2014

The announcement this week by UK pharma giant GlaxoSmithKline that it is mulling a possible initial public…

FinancialGlaxoSmithKlinePharmaceuticalViiV Healthcare

Vaxart accelerates development of Ebola tablet vaccine

24-10-2014

Privately-held US vaccine developer Vaxart says it is accelerating its Ebola tablet vaccine program.…

Anti-viralsPharmaceuticalResearchVaccinesVaxart

Genmab gets latest milestone in daratumumab Janssen collaboration

Genmab gets latest milestone in daratumumab Janssen collaboration

24-10-2014

Danish biotech company Genmab has reached the fourth milestone in its daratumumab collaboration with…

daratumumabDenmarkGenmabJanssenOncologyPharmaceuticalResearch

Acute pain market to grow less than 0.5% between 2013 and 2023, says new research

Acute pain market to grow less than 0.5% between 2013 and 2023, says new research

24-10-2014

The acute pain market will experience only minimal growth between 2013 and 2023, according to biopharma…

AnalgesiaCelebrexDecision Resources GroupMarkets & MarketingPharmaceutical

Stallergenes furthers global expansion and opens affiliate in Ontario, Canada

Stallergenes furthers global expansion and opens affiliate in Ontario, Canada

24-10-2014

Stallergenes, a France-based global healthcare company specialized in diagnosis and treatment of allergies,…

CanadaMarkets & MarketingOralairPharmaceuticalRespiratory and PulmonaryStallergenes

Takeda gains exclusive rights to Amitiza beyond US and Canada

Takeda gains exclusive rights to Amitiza beyond US and Canada

23-10-2014

US biopharma company Sucampo Pharmaceuticals saw its shares rise 5.6% to $8.46 in morning trading, after…

AmitizaGastro-intestinalsGlobalLicensingPharmaceuticalSucampoTakeda Pharmaceutical

Lilly expands collaboration with Zymeworks

Lilly expands collaboration with Zymeworks

23-10-2014

US pharma major Eli Lilly and privately-held Canadian biotech firm Zymeworks have expanded their existing…

CanadaEli LillyLicensingOncologyPharmaceuticalResearchUSAZymeworks

Ferring Pharma’s Cortiment gains EU approval

Ferring Pharma’s Cortiment gains EU approval

23-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says its Cortiment (budesonide) treatment…

CortimentCosmo PharmaceuticalsEuropeFerring PharmaceuticalsGastro-intestinalsPentasaPharmaceuticalRegulation

EMA moves further to push Ebola treatments development

EMA moves further to push Ebola treatments development

23-10-2014

During the past months, the European Medicines Agency has put in place a system to give the best possible…

Anti-viralsEuropePharmaceuticalRegulationResearchVaccines

Cost of Australian PBS rises below rate of inflation for 2013-2014

Cost of Australian PBS rises below rate of inflation for 2013-2014

23-10-2014

The Australian Department of Health has confirmed that growth of the Pharmaceutical Benefits Scheme cost…

AustraliaMedicines AustraliaPharmaceuticalPharmaceuticals policyRegulation

Partnership led by UK Medical Research Council to invest more than $368 million in medical technology

Partnership led by UK Medical Research Council to invest more than $368 million in medical technology

23-10-2014

The UK’s chancellor of the exchequer, George Osborne, has announced that a partnership led by the Medical…

PharmaceuticalResearchUKUnited KingdomWELLCOME TRUST

UK’s NICE backs another use for Bayer’s Xarelto

UK’s NICE backs another use for Bayer’s Xarelto

23-10-2014

In draft guidance published today for consultation, the UK’s health costs watchdog the National Institute…

BayerCardio-vascularPharmaceuticalPricingRegulationUKXarelto

Abbott raises midpoint of EPS guidance and sees shares rise as quarterly profit exceeds forecast

Abbott raises midpoint of EPS guidance and sees shares rise as quarterly profit exceeds forecast

22-10-2014

Shares of US health care company Abbott Laboratories rose slightly in the premarket trading period following…

Abbott LaboratoriesFinancialPharmaceuticalUnited StatesUSA

GlaxoSmithKline’s third-qtr results not as bad as expected

GlaxoSmithKline’s third-qtr results not as bad as expected

22-10-2014

UK pharma giant GlaxoSmithKline has reported a downturn in both sales and profits for the third quarter…

FinancialGlaxoSmithKlinePharmaceuticalThomson ReutersUKViiV Healthcare

Tekmira starts manufacture of new RNAi therapeutic for Ebola

Tekmira starts manufacture of new RNAi therapeutic for Ebola

22-10-2014

Canadian RNA interference (RNAi) therapeutics developer Tekmira Pharmaceuticals says it has commenced…

Anti-viralsCanadaPharmaceuticalProductionResearchTekmira PharmaceuticalsTKM-Ebola

GW Pharmaceuticals granted orphan designation by the EMA for Epidiolex

GW Pharmaceuticals granted orphan designation by the EMA for Epidiolex

22-10-2014

Cannabinoid product specialist GW Pharmaceuticals has been granted orphan designation by the European…

CNS DiseasesepidiolexGW PharmaceuticalsPharmaceuticalResearchUSA

Actavis signs option to acquire relamorelin developer

Actavis signs option to acquire relamorelin developer

22-10-2014

Ireland-headquartered Actavis has been granted an exclusive option to acquire USA-based biopharma company…

ActavisDiabetesGastro-intestinalsIrelandMergers & AcquisitionsPharmaceuticalrelamorelinRhythm Health

New angel investment initiative to boost funding for UK bioscience businesses

New angel investment initiative to boost funding for UK bioscience businesses

22-10-2014

Emerging bioscience companies in the UK will have access to new sources of funding as a result of an…

FinancialLondon Business AngelsPharmaceuticalUKUnited Kingdom

Ferring Pharma regains rights to DDAVP portfolio

Ferring Pharma regains rights to DDAVP portfolio

22-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says it has acquired DDAVP (desmopressin…

DDAVPDiabetesFerring PharmaceuticalsGenito-urinaryLicensingPharmaceuticalSanofiSwitzerland

Roche to invest billions in new R&D facility and Basel updates

Roche to invest billions in new R&D facility and Basel updates

22-10-2014

Swiss pharma major Roche says it will invest 3 billion Swiss francs ($3.2 billion) in new research infrastructure…

FinancialGeography of EuropePharmaceuticalRocheSwitzerland

Ipsen to commercialize Lexicon carcinoid drug ex-North America/Japan

22-10-2014

French drugmaker Ipsen has entered into an accord with Lexicon Pharmaceuticals to commercialize the US…

EuropeIpsenLexicon PharmaceuticalsLicensingOncologyPharmaceuticaltelotristat etiprate

1 to 25 of 7100 results

Back to top